Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
October 26, 2026
A New Jersey federal judge on Monday refused to issue an injunction blocking Eli Lilly & Co. from running ads allegedly comparing its GLP-1 drug to Novo Nordisk Inc.'s using "outdated" clinical trials and "false superiority messages," ruling that Novo Nordisk hasn't shown it would be irreparably harmed.
-
October 26, 2026
The Trump administration is again asking a California federal judge to toss a coalition of states' lawsuit challenging its decision to cut vaccine recommendations for children, arguing that the states cannot show harm that gives them standing to sue.
-
October 26, 2026
Utah-based Nomi Health Inc. sued the U.S. government on Friday, claiming that it failed to provide more than $200 million in promised payments for testing and vaccination services provided to uninsured Americans during the COVID-19 pandemic.
-
October 26, 2026
Obesity-focused biopharmaceutical company Corxel Pharmaceuticals Inc. on Monday unveiled plans to go public by merging with special-purpose acquisition company Amanat Acquisition Corp. in a deal expected to generate roughly $377 million in gross proceeds and that was built by three law firms.
-
October 26, 2026
A Connecticut federal judge carved a different path Friday for two later generic-drug price-fixing cases from state attorneys general, allowing Mylan executives to revoke their previous invocation of the Fifth Amendment unimpeded, after previously allowing the enforcers to challenge that revocation in the first case set for trial.
See more Life Sciences news